Middle East Healthcare Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA141H01UKH9
SAR
34.40
-0.08 (-0.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
2,882.82
2,653.17
2,151.74
1,872.62
1,750.58
1,496.65
1,390.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,882.82
2,653.17
2,151.74
1,872.62
1,750.58
1,496.65
1,390.69
Raw Material Cost
1,826.14
1,681.40
1,505.03
1,304.70
1,201.19
1,040.18
902.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,393.55
1,301.09
1,173.87
1,034.58
925.64
789.89
662.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
224.83
159.81
70.22
52.26
35.93
27.04
12.70
Selling and Distribution Expenses
610.60
603.11
489.42
506.64
438.65
351.27
324.14
Other Expenses
-161.84
-146.09
-124.41
-108.68
-96.16
-81.69
-67.55
Total Expenditure (Excl Depreciation)
2,436.74
2,284.51
1,994.45
1,811.34
1,639.84
1,391.45
1,226.36
Operating Profit (PBDIT) excl Other Income
446.1
368.7
157.3
61.3
110.7
105.19999999999999
164.3
Other Income
42.50
13.28
8.06
10.43
5.87
17.13
12.78
Operating Profit (PBDIT)
704.54
571.24
297.41
212.90
243.83
220.73
266.06
Interest
224.83
159.81
70.22
52.26
35.93
27.04
12.70
Exceptional Items
47.72
-30.68
0.00
0.00
0.00
0.00
6.26
Gross Profit (PBDT)
1,056.68
971.77
646.72
567.92
549.39
456.46
488.47
Depreciation
216.75
189.81
145.97
141.41
127.22
98.41
88.95
Profit Before Tax
310.69
190.94
81.22
19.23
80.69
95.28
170.67
Tax
26.28
170.44
9.62
7.50
5.50
5.18
6.10
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
282.00
17.04
75.18
17.20
81.99
97.57
172.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
282.00
17.04
75.18
17.20
81.99
97.57
172.25
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.88
3.46
-3.58
-5.47
-6.81
-7.46
-7.68
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
283.89
20.50
71.60
11.73
75.19
90.11
164.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,626.11
1,319.61
1,364.96
1,257.55
1,231.73
1,522.72
1,445.74
Earnings per share (EPS)
3.06
0.19
0.82
0.19
0.89
1.06
1.87
Diluted Earnings per share
3.06
0.19
0.82
0.19
0.89
1.06
1.87
Operating Profit Margin (Excl OI)
15.45%
13.88%
6.66%
3.26%
6.33%
7.03%
11.82%
Gross Profit Margin
18.3%
14.35%
10.56%
8.58%
11.88%
12.94%
18.67%
PAT Margin
9.78%
0.64%
3.49%
0.92%
4.68%
6.52%
12.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 8.65% vs 23.31% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 1,284.88% vs -71.37% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 18.64% vs 92.81% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 40.68% vs 127.64% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Middle East Healthcare Co. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
2,882.82
0
2,882.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,882.82
0
2,882.82
Raw Material Cost
1,826.14
0
1,826.14
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,393.55
0
1,393.55
Power Cost
0
0
0.00
Manufacturing Expenses
224.83
0
224.83
Selling and Distribution Expenses
610.60
0
610.60
Other Expenses
-161.84
0.00
-161.84
Total Expenditure (Excl Depreciation)
2,436.74
0
2,436.74
Operating Profit (PBDIT) excl Other Income
446.08
0.00
446.08
Other Income
42.50
0
42.50
Operating Profit (PBDIT)
704.54
0
704.54
Interest
224.83
0
224.83
Exceptional Items
47.72
0
47.72
Gross Profit (PBDT)
1,056.68
0
1,056.68
Depreciation
216.75
0
216.75
Profit Before Tax
310.69
0
310.69
Tax
26.28
0
26.28
Provisions and contingencies
0
0
0.00
Profit After Tax
282.00
0
282.00
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
282.00
0
282.00
Share in Profit of Associates
0
0
0.00
Minority Interest
1.88
0
1.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
283.89
0
283.89
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,626.11
0
1,626.11
Earnings per share (EPS)
3.06
0
3.06
Diluted Earnings per share
3.06
0
3.06
Operating Profit Margin (Excl OI)
15.45%
0%
0.00
15.45%
Gross Profit Margin
18.30%
0%
0.00
18.30%
PAT Margin
9.78%
0%
0.00
9.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 288.28 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.65% vs 23.31% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 28.39 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1,284.88% vs -71.37% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 66.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 18.64% vs 92.81% in Dec 2023

Annual - Interest
Interest 22.48 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.68% vs 127.64% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.45%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023